Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 42.67 USD -1.16%
Market Cap: 2.5B USD
Have any thoughts about
Protagonist Therapeutics Inc?
Write Note

Protagonist Therapeutics Inc
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Protagonist Therapeutics Inc
Long-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Protagonist Therapeutics Inc
NASDAQ:PTGX
Long-Term Investments
$114.6m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Investments
$267m
CAGR 3-Years
-1%
CAGR 5-Years
15%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Investments
$4.7B
CAGR 3-Years
407%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Investments
$8.5B
CAGR 3-Years
14%
CAGR 5-Years
22%
CAGR 10-Years
34%

See Also

What is Protagonist Therapeutics Inc's Long-Term Investments?
Long-Term Investments
114.6m USD

Based on the financial report for Sep 30, 2024, Protagonist Therapeutics Inc's Long-Term Investments amounts to 114.6m USD.

What is Protagonist Therapeutics Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
44%

Over the last year, the Long-Term Investments growth was 5 628%. The average annual Long-Term Investments growth rates for Protagonist Therapeutics Inc have been 44% over the past three years .

Back to Top